chr16-50712018-C-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_001370466.1(NOD2):āc.2026C>Gā(p.Arg676Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000011 in 1,460,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R676C) has been classified as Benign.
Frequency
Consequence
NM_001370466.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NOD2 | NM_001370466.1 | c.2026C>G | p.Arg676Gly | missense_variant | 4/12 | ENST00000647318.2 | NP_001357395.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NOD2 | ENST00000647318.2 | c.2026C>G | p.Arg676Gly | missense_variant | 4/12 | NM_001370466.1 | ENSP00000495993 | P1 | ||
NOD2 | ENST00000300589.6 | c.2107C>G | p.Arg703Gly | missense_variant | 4/12 | 1 | ENSP00000300589 | |||
NOD2 | ENST00000641284.2 | c.2026C>G | p.Arg676Gly | missense_variant, NMD_transcript_variant | 4/6 | ENSP00000493088 | ||||
NOD2 | ENST00000646677.2 | c.2026C>G | p.Arg676Gly | missense_variant, NMD_transcript_variant | 4/13 | ENSP00000496533 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248652Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134888
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1460772Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 726738
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Blau syndrome;CN260071:Inflammatory bowel disease 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 11, 2019 | This sequence change replaces arginine with glycine at codon 703 of the NOD2 protein (p.Arg703Gly). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and glycine. This variant is present in population databases (rs5743277, ExAC 0.01%). This variant has not been reported in the literature in individuals with NOD2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at